Immix Biopharma, Inc. Intellectual Property Contracts & Agreements
2 Contracts & Agreements
- License Agreements (2 contracts)
- Research and License Agreement entered into on December 8, 2022 by and between Nexcella, Inc. (formerly Immix Biopharma Cell Therapy, Inc.), Hadasit Medical Research Services &... (Filed With SEC on December 14, 2022)
- IP License Agreement by and between the Company and Immix Biopharma Australia Pty Ltd dated January 23, 2017 (Filed With SEC on October 6, 2021)
